Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
RLD :
TE Code :
Brand Name : ENBREL
Dosage Form : VIAL; SUBCUTANEOUS
Dosage Strength : 25MG/VIAL
Approval Date :
Application Number : 103795
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : ENBREL
Dosage Form : SYRINGE
Dosage Strength : 50MG/ML
Approval Date :
Application Number : 103795
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : ETICOVO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 25MG/0.5ML
Approval Date :
Application Number : 761066
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : ETICOVO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/1ML
Approval Date :
Application Number : 761066
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : ERELZI
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 25MG/0.5ML
Approval Date :
Application Number : 761042
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : ERELZI
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 50MG/ML
Approval Date :
Application Number : 761042
RX/OTC/DISCN :
RLD :
TE Code :
Regulatory Info :
Registration Country : Australia
Brand Name : Brenzys
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Brenzys
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Brenzys
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Brenzys
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Nepexto
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Enbrel
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Enbrel
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Enbrel
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Enbrel
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Enbrel
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Brand Name : ENBREL
Patent Number : 2366785
Filing Date : 2000-04-19
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Brand Name : ENBREL
Patent Number : 2366785
Filing Date : 2000-04-19
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Patent Expiration Date : 2013-09-14
Date Granted : 2000-03-14
Brand Name : ENBREL
Patent Number : 2123593
Filing Date : 1993-09-14
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2013-09-14
Date Granted : 2000-03-14
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Brand Name : ENBREL
Patent Number : 2045869
Filing Date : 1991-06-27
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Patent Expiration Date : 2023-02-27
Date Granted : 2009-06-16
Brand Name : ENBREL
Patent Number : 2476934
Filing Date : 2003-02-27
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2023-02-27
Date Granted : 2009-06-16
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Brand Name : ENBREL
Patent Number : 2045869
Filing Date : 1991-06-27
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
ABOUT THIS PAGE